AC
XENT
Aisling Capital’s Intersect ENT, Inc XENT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-225,000
| Closed | -$3.86M | – | 16 |
|
|
2017
Q1 | $3.86M | Hold |
225,000
| – | – | 0.7% | 14 |
|
|
2016
Q4 | $2.72M | Sell |
225,000
-23,498
| -9% | -$284K | 0.63% | 15 |
|
|
2016
Q3 | $3.94M | Sell |
248,498
-201,502
| -45% | -$3.19M | 0.81% | 16 |
|
|
2016
Q2 | $5.82M | Buy |
450,000
+100,000
| +29% | +$1.29M | 1.37% | 17 |
|
|
2016
Q1 | $6.65M | Hold |
350,000
| – | – | 1.33% | 17 |
|
|
2015
Q4 | $7.88M | Hold |
350,000
| – | – | 1.36% | 16 |
|
|
2015
Q3 | $8.19M | Hold |
350,000
| – | – | 1.44% | 17 |
|
|
2015
Q2 | $10M | Hold |
350,000
| – | – | 1.49% | 16 |
|
|
2015
Q1 | $9.04M | Hold |
350,000
| – | – | 1.18% | 16 |
|
|
2014
Q4 | $6.49M | Hold |
350,000
| – | – | 0.98% | 16 |
|
|
2014
Q3 | $5.43M | Buy |
+350,000
| New | +$5.43M | 1.05% | 17 |
|